The association of level of reduction of Wilms’ tumor gene 1 mRNA transcript in bone marrow and outcome in acute myeloid leukemia patients-Reference-Cited by-同舟云学术

The association of level of reduction of Wilms’ tumor gene 1 mRNA transcript in bone marrow and outcome in acute myeloid leukemia patients

Published:2015-06 Issue:6 Volume:39 Page:667-671
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Shibasaki Yasuhiko,Seki Yoshinobu,Tanaka Tomoyuki,Miyakoshi Syukuko,Fuse Kyoko,Kozakai Takashi,Kobayashi Hironori,Ushiki Takashi,Abe Takashi,Yano Toshio,Moriyama Masato,Kuroha Takashi,Isahai Noriatsu,Takizawa Jun,Narita Miwako,Koyama Satoru,Furukawa Tatsuo,Sone Hirohito,Masuko Masayoshi

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference24 articles.

1. A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study;Miyawaki;Blood,2011

2. Anthracycline dose intensification in acute myeloid leukemia;Fernandez;N Engl J Med,2009

3. Cytogenetics in acute leukemia;Mrózek;Blood Rev,2004

4. Flt3 mutations and leukaemia;Kottaridis;Br J Haematol,2003

5. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype;Falini;N Engl J Med,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wilms Tumor: Updates about Pathogenesis and New Possible Clinical Treatments of the Most Frequent Pediatric Urogenital Cancer: A Narrative Review;Surgeries;2023-12-08

2. Clinical significance of WT1 in the evaluation of therapeutic effect and prognosis of non-M3 acute myeloid leukemia;Cancer Biology & Therapy;2023-11-30

3. WT1 Expression in Peripheral Blood at Diagnosis and During the Course of Early Consolidation Treatment Correlates With Survival in Patients With Intermediate and Poor-Risk Acute Myeloid Leukemia;Clinical Lymphoma Myeloma and Leukemia;2020-12

4. Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia;JAMA Oncology;2020-12-01

5. Combined usage of Wilms' tumor gene quantitative analysis and multiparameter flow cytometry for minimal residual disease monitoring of acute myeloid leukemia patients after allogeneic hematopoietic stem cells transplantation;Experimental and Therapeutic Medicine;2017-11-23